Palantir's AI Arsenal Faces a High-Stakes Earnings Test

Palantir's Q1 earnings report is a key test amid a Wall Street clash. Bulls cite AI defense contracts and surging revenue, while bears point to extreme valuation and insider selling.

As Palantir Technologies prepares to report first-quarter results, the data analytics firm finds itself at the center of a fierce Wall Street debate. The stock, recently trading at 114.26 EUR with a slight daily gain of 1.73%, is attempting to stabilize after a prolonged sell-off that has left it down roughly 20% year-to-date. The upcoming figures, due after the U.S. market close on May 4, will be scrutinized for signs that can reconcile the extreme views currently surrounding the company.

On one side stands bullish analyst sentiment, exemplified by Wedbush's Dan Ives, who recently dismissed bearish narratives as "fictional." His optimism is fueled by Palantir's deep integration within government agencies and blistering recent growth. The company's fourth-quarter 2025 results showed total revenue surging 70% year-over-year to $1.41 billion, driven by a 137% jump in U.S. commercial revenue and a 66% increase in U.S. government sales. For the full year 2026, management has guided for revenue growth of approximately 61%.

The government business, particularly defense, has become a central pillar. More than half of U.S. revenue now stems from government contracts, including deals with the Pentagon and Immigration and Customs Enforcement (ICE). A key driver is the Maven Smart System, an AI platform actively used by the U.S. military for target identification in the Middle East. This real-world deployment even drew rare public praise from former President Donald Trump on his Truth Social platform, though the associated stock gains proved fleeting.

This political and military reliance is a double-edged sword, providing steady contracts but also exposing Palantir to federal budget debates and geopolitical shifts. Meanwhile, the company's lofty valuation offers little room for error. With a price-to-earnings ratio exceeding 200, the shares trade about 37% below their 52-week high of 179.86 EUR and are far removed from their 200-day moving average at 141.62 EUR.

This valuation is a primary concern for prominent short-seller Michael Burry, who is betting against the stock via put options. He argues Palantir is massively overvalued, especially when compared to rivals like Anthropic. Burry notes that the startup achieved an annual revenue run rate of $30 billion within five years, a milestone it took Palantir two decades to reach with its first $5 billion, suggesting newer competitors offer more intuitive and cost-effective enterprise solutions.

Adding to the cautious backdrop is significant insider selling. Over the past three months, company insiders have sold shares worth $433 million without making a single purchase. Market observers often interpret such activity as a lack of confidence in the current price level.

All eyes are now on the Q1 report. Management has set a revenue target between $1.532 billion and $1.536 billion. Analysts will be watching to see if the triple-digit growth pace in U.S. commercial sales can be sustained and how much military partnerships bolster the bottom line. UBS recently raised its price target from $180 to $200, citing the potential of Palantir's AI Platform (AIP) to synthesize disparate data for defense and healthcare applications, maintaining a consensus "Moderate Buy" rating.

A miss on its own forecast could trigger a test of the stock's 52-week low at 81.39 EUR. The earnings release, followed by a management webcast at 5:00 p.m. ET, will determine whether fundamental growth can finally outweigh the towering valuation concerns and insider skepticism.